Get information about COVID-19 vaccinations, testing and visiting standards. Learn More.

Clinical guidelines and decision support

Children’s Minnesota has created a number of clinical practice guidelines for health professionals that highlight an evidence-based approach to the management of certain conditions in order to reduce unwarranted variation in care.

Guidelines are designed to apply to the bulk of patients with a given condition and should be adapted to individual patients based upon clinical judgment and individual situations. To assist providers with real-time decision making, most of the clinical guidelines at Children’s Minnesota consist of visual treatment algorithms/pathways, evidence-based ordersets, bibliographies and any applicable rules/alerts embedded within the electronic health record. In addition to clinical guidelines in pdf format listed below, more than 25 of the Children’s Minnesota clinical guidelines are available in interactive digital format through an avoMD guidelines application, which is accessible for providers on internal platforms and mobile devices.

Brief Resolved Unexplained Event (BRUE)

Brief Resolved Unexplained Event (BRUE) Guideline

Bronchiolitis

Bronchiolitis Guideline

Button Battery Ingestion

Button Battery Guideline

Cannabinoid Hyperemesis Syndrome

Cannabinoid Hyperemesis Syndrome Guideline

Cardiac Rehabilitation

Cardiac Rehabilitation Guideline

Cervical Spine Clearance

Cervical Spine Clearance Guideline

Congenital CMV Guideline

Congenital CMV Guideline

Clostridioides Difficile Infection (CDI)

C. Difficile Testing Guideline C. Difficile Treatment Algorithm

COVID-19 (Coronavirus) Interim Guidelines

Coronavirus Interim Guidelines have not been through the formal guideline governance council review process but have been approved for interim use by clinical leaders. They should be viewed as interim guidelines and will be updated frequently as the situation evolves. Health care providers should also refer to external sources such as CDC.gov and the Minnesota Department of Health for additional resources for this dynamic situation. Diagnostic testing strategy Medical Management for patients with confirmed COVID-19 Suspected MIS-C management recommendations VTE Prophylaxis in COVID-19 patients – see below under VTE Risk Stratification in Hospitalized Patients (includes Patients with COVID) Paxlovid Prescribing Process

Croup

Croup Guideline: Age 3 Months-8 Years

Fever ≥ 38.0°C (100.4°F) Without Obvious Source (Infant 1-60 Days)

Febrile Infant ED/Inpatient Guideline

Fever and Neutropenia

Fever and Neutropenia Treatment Guideline

High Flow Nasal Cannula

High Flow Nasal Cannula Guideline

Hypothermia, Accidental – Trauma

Accidental Primary Hypothermia (HT) Guideline

Kawasaki Disease

Kawasaki Disease Guideline

Suspected Kidney Stone

Suspected Kidney Stone

Open Fracture – Trauma

Antibiotic Prophylaxis in Patients with Open Fractures

Opioid Withdrawal Guideline

Opioid Withdrawal Guideline

Otitis Media

Otitis Media Guideline

Urinary Tract Infections (UTI)

Urinary Tract Infections Guideline
Guidelines are updated periodically in keeping with emerging evidence. Each guideline contains an important disclaimer and users must proceed at their own risk accordingly: This guideline is designed for general use with most patients; each clinician should use his or her own independent judgment to meet the needs of each individual patient. This guideline is not a substitute for professional medical advice, diagnosis or treatment. For more information, email [email protected].

24/7 access to referrals, consults and admissions. Learn more.
Intended only for health care providers. Patients, please contact your doctor directly.